JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toda, N.
Right arrow Articles by Okamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toda, N.
Right arrow Articles by Okamura, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NICOTINE
*NICOTINE TARTRATE
*NITRIC OXIDE
*NITROGLYCERIN

Role of nitric oxide in neurally induced cerebroarterial relaxation

N Toda and T Okamura

Department of Pharmacology, Shiga University of Medical Sciences, Ohtsu, Japan.

Transmural electrical stimulation and nicotine produced a relaxation of dog cerebral artery strips denuded of endothelium, which was abolished by tetrodotoxin and hexamethonium, respectively, and also suppressed by treatment with NG-nitro-L-arginine (L-NA), a nitric oxide (NO) synthesis inhibitor. The inhibition was reversed by L-arginine but not by the D-enantiomer. L-NA also suppressed the endothelium-dependent relaxation by substance P but not the response to NO and nitroglycerin. Treatment with high concentrations of nitroglycerin or sodium nitroprusside markedly inhibited the relaxant response to nicotine, substance P and NO but not the response to papaverine. Slight, slowly developing relaxations caused by L-arginine in the endothelium-denuded arteries were not potentiated by repeated applications of the amino acid or by exposure of the strips for 24 hr to the bathing medium. Ca++ ionophore-induced contractions in the denuded strips were not potentiated by L-NA. Nicotine significantly increased the level of cyclic GMP in the arteries without endothelium; the increment was abolished by treatment with L-NA and hexamethonium. NO does not seem to be synthesized in smooth muscle in an amount sufficient to produce significant relaxation. It may be concluded that NO liberated from vasodilator nerves activates guanylate cyclase in smooth muscle and produces cyclic GMP, resulting in cerebroarterial relaxation.

Volume 258, Issue 3, pp. 1027-1032, 09/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda and T. Okamura
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. M. Mbaku, L. Zhang, W. J. Pearce, S. P. Duckles, and J. Buchholz
Chronic hypoxia alters the function of NOS nerves in cerebral arteries of near-term fetal and adult sheep
J Appl Physiol, February 1, 2003; 94(2): 724 - 732.
[Abstract] [Full Text] [PDF]


Home page
Chem SensesHome page
G. Zaccone, C. Crescimanno, P. Lo Cascio, A. Mauceri, S. Fasulo, and A. Sbarbati
Immunohistochemical Investigation of the Nitrergic System in the Taste Organ of the Frog, Rana esculenta
Chem Senses, November 1, 2002; 27(9): 825 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Buchholz and S. P. Duckles
Chronic hypoxia alters prejunctional {alpha}2-receptor function in vascular adrenergic nerves of adult and fetal sheep
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R926 - R934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Zoccoli, D. A. Grant, J. Wild, and A. M. Walker
Nitric oxide inhibition abolishes sleep-wake differences in cerebral circulation
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2598 - H2606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Ayajiki, T. Tanaka, T. Okamura, and N. Toda
Evidence for nitroxidergic innervation in monkey ophthalmic arteries in vivo and in vitro
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H2006 - H2012.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. N. Mbaku, L. Zhang, S. P. Duckles, and J. Buchholz
Nitric-Oxide Synthase-Containing Nerves Facilitate Adrenergic Transmitter Release in Sheep Middle Cerebral Arteries
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 397 - 402.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Buchholz, K. Edwards-Teunissen, and S. P. Duckles
Impact of development and chronic hypoxia on NE release from adrenergic nerves in sheep arteries
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R799 - R808.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Iwasaki, M. Notoya, Y. Hayasaki-Kajiwara, T. Shimamura, N. Naya, M. Ninomiya, and M. Nakajima
Endothelium-independent vascular relaxation mediating ETB receptor in rabbit mesenteric arteries
Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H383 - H390.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. L. Kellogg Jr., C. G. Crandall, Y. Liu, N. Charkoudian, and J. M. Johnson
Nitric oxide and cutaneous active vasodilation during heat stress in humans
J Appl Physiol, September 1, 1998; 85(3): 824 - 829.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Shastry, N. M. Dietz, J. R. Halliwill, A. S. Reed, and M. J. Joyner
Effects of nitric oxide synthase inhibition on cutaneous vasodilation during body heating in humans
J Appl Physiol, September 1, 1998; 85(3): 830 - 834.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Okamura, H. Fujioka, K. Ayajiki, and N. Toda
Modifications by Superoxide-Generating Agent, Neurotransmitters and Neuromodulators of Nitroxidergic Nerve Function in Monkey Cerebral Arteries
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1321 - 1325.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Toda, M. Toda, K. Ayajiki, and T. Okamura
Cholinergic nerve function in monkey ciliary arteries innervated by nitroxidergic nerve
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1582 - H1589.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Joyner and N. M. Dietz
Nitric oxide and vasodilation in human limbs
J Appl Physiol, December 1, 1997; 83(6): 1785 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C. H BUCKLEY, P. W F HADOKE, and C. J O'BRIEN
Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma
Br. J. Ophthalmol., July 1, 1997; 81(7): 599 - 607.
[Full Text] [PDF]


Home page
CirculationHome page
D. Giugliano, R. Marfella, L. Coppola, G. Verrazzo, R. Acampora, R. Giunta, F. Nappo, C. Lucarelli, and F. D'Onofrio
Vascular Effects of Acute Hyperglycemia in Humans Are Reversed by L-Arginine : Evidence for Reduced Availability of Nitric Oxide During Hyperglycemia
Circulation, April 1, 1997; 95(7): 1783 - 1790.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. F. Dominiczak and D. F. Bohr
Nitric Oxide and Its Putative Role in Hypertension
Hypertension, June 1, 1995; 25(6): 1202 - 1211.
[Full Text]


Home page
ScienceHome page
S. Snyder
Nitric oxide: first in a new class of neurotransmitters
Science, July 24, 1992; 257(5069): 494 - 496.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.